Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This multicenter prospective observational cohort study aims to develop and validate individualized risk prediction models for stroke and cognitive decline in patients with moyamoya disease or moyamoya syndrome by integrating clinical characteristics, laboratory data, multimodal neuroimaging, genetic information, and other available multidimensional data. Approximately 3,000 participants will be enrolled and followed for up to 24 months.
Epistemonikos ID: 628a3d89b952121d459908a9597a71d7a03e6ac5
First added on: Oct 27, 2026